Back to Search
KAMAL HAMED, M.D.
M.D.
Infectious Disease Physician
NPI: 1679747844Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
25MA05391600(NJ)
Research & Publications (20)
Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.
PMID 19192993·Curr Med Res Opin·2009
2-rct
Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection.
PMID 19273678·Antimicrob Agents Chemother·2009
3-trial
Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
PMID 18637755·Clin Infect Dis·2008
4-observational
Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes.
PMID 16957911·Arch Gynecol Obstet·2007
6-review
Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
PMID 17538513·Sex Transm Dis·2007
4-observational
Salamander abundance along road edges and within abandoned logging roads in Appalachian forests.
PMID 17298522·Conserv Biol·2007
7-preclinical
Short-course therapy for recurrent genital herpes and herpes labialis.
PMID 17217895·J Fam Pract·2007
6-review
Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
PMID 16781291·J Am Acad Dermatol·2006
4-observational
Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
PMID 16323085·Clin Infect Dis·2006
4-observational
Single-day famciclovir therapy for recurrent genital herpes.
PMID 16834829·Curr Med Res Opin·2006
3-trial
Single-dose famciclovir for the treatment of herpes labialis.
PMID 16968573·Curr Med Res Opin·2006
8-other
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure.
PMID 16028153·Clin Infect Dis·2005
6-review
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
PMID 15818288·Pediatr Infect Dis J·2005
3-trial
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
PMID 15818287·Pediatr Infect Dis J·2005
3-trial
Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.
PMID 15498622·J Emerg Med·2004
3-trial
Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure.
PMID 14614365·Pediatr Infect Dis J·2003
3-trial
Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
PMID 14614364·Pediatr Infect Dis J·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 HEALTH PLZ
EAST HANOVER, NJ 07936 - Phone
- (862) 778-4780
Quick Facts
- NPI
- 1679747844
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile